Evidence map›Paper›PMID 26792207›Full record

ArticleThe Journal of allergy and clinical immunology2016

Transient receptor potential cation channel, subfamily V, member 4 and airway sensory afferent activation: Role of adenosine triphosphate.

Sara J Bonvini, Mark A Birrell, Megan S Grace, Sarah A Maher, John J Adcock, Michael A Wortley, Eric Dubuis, Yee-Man Ching, Anthony P Ford, Fisnik Shala and 4 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it, 124 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Research Progress on Upper Airway Cough Syndrome.World journal of otorhinolaryngology - head and neck surgery · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Targeting P2X Receptors-Current Progress in Sepsis.International journal of inflammation · 2025
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Sara J BonviniRespiratory Pharmacology Group, Airway Disease Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Mark A BirrellRespiratory Pharmacology Group, Airway Disease Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Megan S GraceSchool of Medical Sciences and Health Innovations Research Institute, RMIT University, Bundoora, Australia.
Sarah A MaherRespiratory Pharmacology Group, Airway Disease Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
John J AdcockRespiratory Pharmacology Group, Airway Disease Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Michael A WortleyRespiratory Pharmacology Group, Airway Disease Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Eric DubuisRespiratory Pharmacology Group, Airway Disease Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Yee-Man ChingAirway Disease Infection Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Anthony P FordAfferent Pharmaceuticals, San Mateo, Calif.
Fisnik ShalaRespiratory Pharmacology Group, Airway Disease Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Montserrat MiralpeixRespiratory Therapeutic Area-Discovery, R&D Centre, Almirall S.A., Barcelona, Spain.
Gema TarrasonRespiratory Therapeutic Area-Discovery, R&D Centre, Almirall S.A., Barcelona, Spain.
Jaclyn A SmithRespiratory and Allergy Centre, University of Manchester, University Hospital of South Manchester, Manchester, United Kingdom.
Maria G BelvisiRespiratory Pharmacology Group, Airway Disease Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom. Electronic address: m.belvisi@imperial.ac.uk.
Imperial College London · GBAlmirall (Spain) · ESRMIT University · AUUniversity of Manchester · GB

Funding

Medical Research Council G0701918Medical Research Council G0800195Medical Research Council MR/K015141/1Medical Research Council MR/K020293/1
6 · The paper itself

Abstract

backgroundSensory nerves innervating the airways play an important role in regulating various cardiopulmonary functions, maintaining homeostasis under healthy conditions and contributing to pathophysiology in disease states. Hypo-osmotic solutions elicit sensory reflexes, including cough, and are a potent stimulus for airway narrowing in asthmatic patients, but the mechanisms involved are not known. Transient receptor potential cation channel, subfamily V, member 4 (TRPV4) is widely expressed in the respiratory tract, but its role as a peripheral nociceptor has not been explored.

objectiveWe hypothesized that TRPV4 is expressed on airway afferents and is a key osmosensor initiating reflex events in the lung.

methodsWe used guinea pig primary cells, tissue bioassay, in vivo electrophysiology, and a guinea pig conscious cough model to investigate a role for TRPV4 in mediating sensory nerve activation in vagal afferents and the possible downstream signaling mechanisms. Human vagus nerve was used to confirm key observations in animal tissues.

resultsHere we show TRPV4-induced activation of guinea pig airway-specific primary nodose ganglion cells. TRPV4 ligands and hypo-osmotic solutions caused depolarization of murine, guinea pig, and human vagus and firing of Aδ-fibers (not C-fibers), which was inhibited by TRPV4 and P2X3 receptor antagonists. Both antagonists blocked TRPV4-induced cough.

conclusionThis study identifies the TRPV4-ATP-P2X3 interaction as a key osmosensing pathway involved in airway sensory nerve reflexes. The absence of TRPV4-ATP-mediated effects on C-fibers indicates a distinct neurobiology for this ion channel and implicates TRPV4 as a novel therapeutic target for neuronal hyperresponsiveness in the airways and symptoms, such as cough.

Indexed as

Adenosine TriphosphateAnimalsCalcium SignalingCoughDose-Response Relationship, DrugGuinea PigsMaleMiceMice, KnockoutNerve Fibers, MyelinatedNeurons, AfferentNodose GanglionPurinergic P2X Receptor AntagonistsRespiratory SystemTRPV Cation ChannelsVagus NerveAdenosine TriphosphatePurinergic P2X Receptor AntagonistsTRPV Cation ChannelsATPcoughhypotonicityion channelssensory nervesTransient receptor potentialvagus

Identifiers

PMID26792207
PMCPMC4929136
OpenAlexW2240077590

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.